Amgen takes on Emcure over Sensipar generic
10-09-2018
Court grants order to resolve Amgen v FDA paediatric dispute
06-06-2017
Amgen sues Apotex over Sensipar generic
14-10-2016
Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride).
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Amgen, Amneal, Hatch-Waxman, generics, Robins Kaplan, Sensipar, patent infringement, kidney disease
